No matter what business it’s been in — smartphones, enterprise software, messaging or embedded automotive software — BlackBerry Ltd. (NYSE:BB) has worked hard to craft an identity around security. However, BB stock was in the headlines on Tuesday when it was announced tha
Today was supposed to be a momentous day for popular cryptocurrency Bitcoin (CRYPTO:BTC). And I suppose it was, but not for the reason everyone thought. Today, El Salvador officially made Bitcoin legal tender, causing many to think the price would spike. Instead, the price of Bitc
Here's Advertisement
Uranium mining stock Cameco (NYSE:CCJ) was on fire this week, gaining 24.2% as of 2:30 p.m. EDT Friday, making it one of the biggest weekly gains for the stock so far this year.
There’s so much happening in the uranium industry that bulls in Cameco haven’t been this excited in a long time.
So what
To start, Cameco shares won two big analyst upgrades this week.
Oil and gas stocks sizzled today, thanks to a surprise forecast from the Organization of Petroleum Exporting Countries (OPEC). Some of the lesser-known stocks surged the most on Sept. 13, with the following leading the pack as of 2 p.m. EDT.
Centennial Resource Development (NA
Getty Images
The Nasdaq Composite managed to set new all-time highs on Wednesday, but that belied a much more mixed session for stocks as investors digested a few fresh economic reports.
Today's headliner was an extremely weak August employment reading – a precursor to F
Shares of Apple's (NASDAQ:AAPL) fell 3.3% on Friday after a federal judge made a decision that could have wide-ranging implications for the tech industry.
So whatU.S. District Judge Yvonne Gonzalez Rogers issued an injunction that will prohibit Apple from denying develope
Mobile game developer AppLovin (NASDAQ:APP) won plenty of affection from the market on Tuesday. The company's shares rose by just under 12% on the day, thanks to a fresh recommendation upgrade from an analyst.
So whatTuesday morning, Morgan Stanley prognosticator Brian Nowa
The U.S. Food and Drug Administration (FDA) approved Comirnaty -- the COVID-19 vaccine co-developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) -- for use in people aged 16 and older on Monday. The news drove shares of Pfizer and BioNTech up 2.5% and 9.6%, respectively. Fell
Here's Advertisement